Compare Citius Pharmaceuticals Inc (CTXR) vs Global X Lithium & Battery Tech ETF (LIT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs Global X Lithium & Battery Tech ETF — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while Global X Lithium & Battery Tech ETF trades at $75.2. The key difference: Global X Lithium & Battery Tech ETF is trading nearer its 52-week high, Citius Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| CTXR | LIT | |
|---|---|---|
Market Cap | $20.01M | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $1.82 | $91.62 |
52-Week Low | $0.48 | $44.96 |
Enterprise Value | $16.23M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About Global X Lithium & Battery Tech ETF
LIT invests in the full lithium cycle, from mining and refining to battery production and EV manufacturing. It tracks the Solactive Global Lithium Index, with top holdings including Rio Tinto, Albemarle, and Tesla, as well as major battery makers like Samsung SDI.
Read more on LIT →
